EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 11 (2025) SICOT-J, 11 (2025) 17 References
Open Access
Issue
SICOT-J
Volume 11, 2025
Article Number 17
Number of page(s) 6
Section Hip
DOI https://doi.org/10.1051/sicotj/2025012
Published online 13 March 2025
  1. Karam JA, Schwenk ES, Parvizi J (2021) An update on multimodal pain management after total joint arthroplasty. J Bone Joint Surg Am 103(17), 1652–1662. [CrossRef] [PubMed] [Google Scholar]
  2. Halawi MJ, Grant SA, Bolognesi MP (2015) Multimodal analgesia for total joint arthroplasty. Orthopedics 38(7), e616–e625. [PubMed] [Google Scholar]
  3. Kelley TC, Adams MJ, Mulliken BD, Dalury DF (2013) Efficacy of multimodal perioperative analgesia protocol with periarticular medication injection in total knee arthroplasty: a randomized, double-blinded study. J Arthroplasty 28(8), 1274–1277. [CrossRef] [PubMed] [Google Scholar]
  4. Ranawat AS, Ranawat CS (2007) Pain management and accelerated rehabilitation for total hip and total knee arthroplasty. J Arthroplasty 22(7 Suppl 3), 12–15. [CrossRef] [PubMed] [Google Scholar]
  5. Mullaji A, Kanna R, Shetty GM, Chavda V, Singh DP (2010) Efficacy of periarticular injection of bupivacaine, fentanyl, and methylprednisolone in total knee arthroplasty: a prospective, randomized trial. J Arthroplasty 25(6), 851–857. [CrossRef] [PubMed] [Google Scholar]
  6. Dasta J, Ramamoorthy S, Patou G, Sinatra R (2012) Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting. Curr Med Res Opin 28(10), 1609–1615. [CrossRef] [PubMed] [Google Scholar]
  7. Yu SW, Szulc AL, Walton SL, Davidovitch RI, Bosco JA, Iorio R (2016) Liposomal bupivacaine as an adjunct to postoperative pain control in total hip arthroplasty. J Arthroplasty 31(7), 1510–1515. [CrossRef] [PubMed] [Google Scholar]
  8. Dysart SH, Barrington JW, Del Gaizo DJ, Sodhi N, Mont MA (2019) Local infiltration analgesia with liposomal bupivacaine improves early outcomes after total knee arthroplasty: 24-hour data from the PILLAR study. J Arthroplasty 34(5), 882–886-e1. [CrossRef] [PubMed] [Google Scholar]
  9. Navathe AS, Troxel AB, Liao JM, et al. (2017) Cost of joint replacement using bundled payment models. JAMA Intern Med 177(2), 214–222. [CrossRef] [PubMed] [Google Scholar]
  10. Ji YD, Harris JA, Gibson LE, McKinley SK, Phitayakorn R (2021) The efficacy of liposomal bupivacaine for opioid and pain reduction: a systematic review of randomized clinical trials. J Surg Res 264, 510–533. [CrossRef] [PubMed] [Google Scholar]
  11. Fanelli G, Casati A, Beccaria P, et al. (1998) A double-blind comparison of ropivacaine, bupivacaine, and mepivacaine during sciatic and femoral nerve blockade. Anesth Analg 87(3), 597–600. [CrossRef] [PubMed] [Google Scholar]
  12. Kocum A, Turkoz A, Ulger H, Sener M, Arslan G (2007) Ropivacaine 0.25% is as effective as bupivacaine 0.25% in providing surgical anaesthesia for lumbar plexus and sciatic nerve block in high-risk patients: preliminary report. Anaesth Intensive Care 35(4), 510–514. [CrossRef] [PubMed] [Google Scholar]
  13. Ritter MA, Koehler M, Keating EM, Faris PM, Meding JB (1999) Intra-articular morphine and/or bupivacaine after total knee replacement. J Bone Joint Surg Br 81(2), 301–303. [CrossRef] [Google Scholar]
  14. Kim JJ, Franczyk M, Gottlieb LJ, Song DH (2017) Cost-effective alternative for negative-pressure wound therapy. Plast Reconstr Surg Glob Open 5(2), e1211. [CrossRef] [PubMed] [Google Scholar]
  15. U.S. Food and Drug Administration, Center for Drug Evaluation and Research (2011). EXPAREL NDA 022496 Approval letter. [Google Scholar]
  16. Asche CV, Dagenais S, Kang A, Ren J, Maurer BT (2019) Impact of liposomal bupivacaine on opioid use, hospital length of stay, discharge status, and hospitalization costs in patients undergoing total hip arthroplasty. J Med Econ 22(12), 1253–1260. [CrossRef] [PubMed] [Google Scholar]
  17. Jacob BC, Peasah SK, Shogbon AO, PerlowER (2017) Postoperative pain management with liposomal bupivacaine in patients undergoing orthopedic knee and hip arthroplasty at a community hospital. Hosp Pharm 52(5), 367–373. [CrossRef] [PubMed] [Google Scholar]
  18. Pichler L, Poeran J, Zubizarreta N, et al. (2018) Liposomal bupivacaine does not reduce inpatient opioid prescription or related complications after knee arthroplasty: a database analysis. Anesthesiology 129(4), 689–699. [CrossRef] [PubMed] [Google Scholar]
  19. Chen JJ, Wu YC, Wang JS, Lee CH (2023) Liposomal bupivacaine administration is not superior to traditional periarticular injection for postoperative pain management following total knee arthroplasty: a meta-analysis of randomized controlled trials. J Orthop Surg Res 18(1), 206. [CrossRef] [PubMed] [Google Scholar]
  20. Hamilton TW, Knight R, Stokes JR, et al. (2022) Efficacy of liposomal bupivacaine and bupivacaine hydrochloride vs bupivacaine hydrochloride alone as a periarticular anesthetic for patients undergoing knee replacement: a randomized clinical trial. JAMA Surg 157(6), 481–489. [CrossRef] [PubMed] [Google Scholar]
  21. Perets I, Walsh JP, Mu BH, et al. (2018) Intraoperative infiltration of liposomal bupivacaine vs bupivacaine hydrochloride for pain management in primary total hip arthroplasty: a prospective randomized trial. J Arthroplasty 33(2), 441–446. [CrossRef] [PubMed] [Google Scholar]
  22. Johnson RL, Amundson AW, Abdel MP, et al. (2017) Continuous posterior lumbar plexus nerve block versus periarticular injection with ropivacaine or liposomal bupivacaine for total hip arthroplasty: a three-arm randomized clinical trial. J Bone Joint Surg Am 99(21), 1836–1845. [CrossRef] [PubMed] [Google Scholar]
  23. Ma TT, Wang YH, Jiang YF, et al. (2017) Liposomal bupivacaine versus traditional bupivacaine for pain control after total hip arthroplasty: A meta-analysis. Medicine (Baltimore) 96(25), e7190. [CrossRef] [PubMed] [Google Scholar]
  24. Bravin LN, Ernest EP, Dietz MJ, Frye BM (2020) Liposomal bupivacaine offers no benefit over ropivacaine for multimodal periarticular injection in total knee arthroplasty. Orthopedics 43(2), 91–96. [CrossRef] [PubMed] [Google Scholar]
  25. Chahar P, Cummings KC, 3rd (2012) Liposomal bupivacaine: a review of a new bupivacaine formulation. J Pain Res 5, 257–264. [PubMed] [Google Scholar]
  26. Ostro MJ, Cullis PR (1989) Use of liposomes as injectable-drug delivery systems. Am J Hosp Pharm 46(8), 1576–1587. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.